This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Enaritide

APEPTICO GmbH

Drug Names(s): enaritide, AP318

Description: Enaritide is a peptide that targets mutant forms of amiloride-sensitive epithelial sodium channels (ENaCs) present in patients with pseudohypoaldosteronism (PHA) type 1b.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug